Carbocysteine Modifies Circulating miR-21, IL-8, sRAGE, and fAGEs Levels in Mild Acute Exacerbated COPD Patients: A Pilot Study

Patients with Chronic Obstructive Pulmonary Disease (COPD) periodically experience acute exacerbation (AECOPD). Carbocysteine represents a valid add on therapy in COPD by exerting antioxidant and anti-inflammatory activities. The in vivo effects of carbocysteine on inflammatory markers are not yet f...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferraro, Maria, Di Vincenzo, Serena, Sangiorgi, Claudia, Leto Barone, Stefania, Gangemi, Sebastiano, Lanata, Luigi, Pace, Elisabetta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880736/
https://www.ncbi.nlm.nih.gov/pubmed/35215330
http://dx.doi.org/10.3390/ph15020218

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8880736/
https://www.ncbi.nlm.nih.gov/pubmed/35215330
http://dx.doi.org/10.3390/ph15020218

Ejemplares similares